Everything You Need to Know About Anticipation for Step 1

Anticipation is one of those genetics buzzwords that shows up everywhere on Step 1 questions and then quietly decides your score hinges on whether you remember which disorders expand and who gets hit harder in the next generation. Let’s lock it down: what anticipation actually means, why it happens, which diseases are classic, and how to recognize it in vignettes—plus the First Aid tie-ins you’re expected to know cold.

---

What Is Anticipation?

Anticipation is a genetic phenomenon where a disease:

• Presents at an earlier age in successive generations, and/or
• Becomes more severe in successive generations

It’s classically seen in disorders caused by unstable repeat expansions, especially trinucleotide repeat expansions.

One-liner you should memorize:

💡

Anticipation = repeat expansion → earlier onset + increased severity in later generations.

---

Pathophysiology: Why Anticipation Happens

The core mechanism: unstable repeat expansion

Many genes contain repeat sequences (often CAG, CGG, CTG, etc.). During gametogenesis, DNA polymerase can “slip,” leading to repeat expansion. If the repeat number crosses a threshold, the gene’s function changes (loss of function, gain of function, toxic RNA, etc.).

Key Step concept:

• Repeat length often correlates with severity and age of onset (more repeats = worse/earlier).

Parent-of-origin effects (high-yield)

Some repeat expansion disorders expand more with:

• Paternal transmission (classically Huntington disease)
• Maternal transmission (classically myotonic dystrophy and Fragile X—especially congenital/severe presentations)

This gets tested as “worse when inherited from dad vs mom.”

---

The Big Three (Plus One) You Must Know

High-yield table: Anticipation disorders at a glance

USMLE nuance: “Anticipation” is most classically tied to AD trinucleotide repeat disorders (Huntington, myotonic dystrophy) and Fragile X (X-linked dominant with methylation). Friedreich ataxia is AR but still due to repeat expansion and may show earlier onset with more repeats.

---

Clinical Presentation: How It Shows Up in Vignettes

The classic “anticipation” vignette pattern

You’ll often see:

• A grandparent with mild disease onset in midlife
• A parent with earlier onset
• A child with very early onset and more severe phenotype

Then the stem asks:

• “What is the underlying mechanism?”
• “What explains increased severity in successive generations?”
• “What type of mutation is responsible?”
• “Which parent likely transmitted the allele?”

Disease-specific high-yield clinical patterns

Huntington disease (CAG, AD, paternal anticipation)

Look for:

• Chorea
• Psychiatric changes (depression, irritability)
• Cognitive decline/dementia
• Family history that “gets worse earlier”

Board-style clue:

• “Father developed symptoms at 50; son develops symptoms at 35.”

Fragile X (CGG, X-linked dominant, maternal expansion)

Look for:

• Intellectual disability (more common/severe in males)
• Autism-like behaviors
• Long face, large ears
• Macroorchidism (post-pubertal)
• Sometimes mitral valve prolapse

Board-style clue:

• “Affected maternal grandfather mildly affected; grandsons more severely affected.”

Myotonic dystrophy type 1 (CTG, AD, maternal severe forms)

Look for:

• Myotonia (difficulty releasing hand grip)
• Muscle wasting (often distal)
• Early cataracts
• Cardiac conduction defects
• Endocrine issues (testicular atrophy, insulin resistance)

Board-style clue:

• “Mother mildly affected; newborn has severe hypotonia/respiratory insufficiency (congenital myotonic dystrophy).”

---

Diagnosis: What Step 1 vs Step 2 Cares About

Step 1 focus (mechanism + mutation type)

• PCR sizing for repeat number (often referenced conceptually)
• Southern blot historically used for very large expansions (classically taught with Fragile X)
• Understand the mutation class:
  • Dynamic mutation (repeat expansion)
  • Gain of function (e.g., Huntington polyglutamine toxicity)
  • Gene silencing via methylation (Fragile X)

Step 2 focus (clinical confirmation + counseling)

• Confirm diagnosis with genetic testing
• Genetic counseling:
  • Discuss anticipation risk in offspring
  • Discuss parent-of-origin patterns
  • Address psychosocial implications (e.g., predictive testing in Huntington)

Testable ethics note (often Step 2-style):
Predictive testing for adult-onset diseases (e.g., Huntington) should include informed consent and counseling, and is generally not performed in minors unless there’s a direct medical benefit during childhood.

---

Treatment & Management (What You’re Expected to Know)

Anticipation itself isn’t “treated”—you treat the underlying disease and counsel about inheritance.

Huntington disease

• Symptomatic management:
  • Tetrabenazine or deutetrabenazine for chorea (VMAT2 inhibitors)
  • Antipsychotics may help chorea + psych symptoms
• Supportive care: PT/OT, psych support, safety planning

Fragile X syndrome

• No cure; management is supportive:
  • Early intervention, special education
  • Behavioral therapy
  • Treat comorbid ADHD/anxiety when present

Myotonic dystrophy

• Symptomatic:
  • Manage arrhythmias (screen with ECG; pacer if indicated)
  • PT/OT
  • Treat cataracts, endocrine issues

USMLE framing: Questions often ask for the mechanism (repeat expansion), not detailed pharmacology. But recognizing “supportive + symptomatic” is fair game.

---

High-Yield Associations & “Gimme” Facts

1) Match repeats to disease (classic Step 1 reflex table)

• CAG: Huntington (also “polyglutamine diseases”—CAG codes glutamine)
• CGG: Fragile X
• CTG: Myotonic dystrophy
• GAA: Friedreich ataxia

2) Parent-of-origin matters

• Huntington: worse with paternal transmission
• Fragile X: expansion typically through maternal transmission
• Myotonic dystrophy: congenital severe forms often maternal

3) Know what “dynamic mutation” means

Unlike a point mutation, this mutation can change in size across generations—that’s the whole reason anticipation exists.

4) Anticipation often implies autosomal dominant inheritance (but not always)

Many classic anticipation stems are AD, but don’t let that blind you—Fragile X is X-linked dominant and Friedreich ataxia is AR with repeat expansion.

---

How Anticipation Gets Tested: Rapid-Fire Vignette Translation

If the question says…

• “Earlier onset in each generation” → think anticipation
• “Trinucleotide repeat expansion” → identify disease based on repeat + phenotype
• “More severe when inherited from father” → Huntington
• “Child severely affected; mother mildly affected; myotonia” → myotonic dystrophy
• “Macroorchidism + autism + long face” → Fragile X

---

First Aid Cross-References (Where This Lives in FA)

In First Aid for the USMLE Step 1, anticipation is primarily emphasized in:

• Genetics → Trinucleotide repeat disorders
  • Huntington disease (CAG, AD, Chr 4, caudate atrophy)
  • Fragile X syndrome (CGG, FMR1 methylation/silencing, X-linked)
  • Myotonic dystrophy (CTG, AD, myotonia + cataracts + cardiac issues)
  • Friedreich ataxia (GAA, AR, ataxia + cardiomyopathy)

How to use FA efficiently here:
Make one mini-table in the margin mapping repeat → disease → inheritance → hallmark symptom. That single move pays off repeatedly on NBME-style questions.

---

Quick Self-Check (If You Can Answer These, You’re Set)

1. A disorder worsens and appears earlier each generation. What’s the mutation type?
2. Which condition shows paternal anticipation with chorea and dementia?
3. Which repeat is associated with Fragile X, and what’s the molecular consequence?
4. What’s the classic triad of myotonic dystrophy associations beyond myotonia?

---

Bottom Line

Anticipation is your clue that you’re dealing with a dynamic repeat expansion disorder. On USMLE, the money is in (1) recognizing the pattern across generations, (2) matching repeat sequences to diseases, and (3) remembering parent-of-origin patterns—especially paternal Huntington and maternal Fragile X/myotonic dystrophy.